Amanote Research
Register
Sign In
Correction: Topoisomerase I Inhibition by NSC 725776 and NSC 724998
Cancer Research
- United States
doi 10.1158/0008-5472.can-67-24-cor1
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
December 15, 2007
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Liquid Chromatography–tandem Mass Spectrometric Assay for the Quantitation in Human Plasma of the Novel Indenoisoquinoline Topoisomerase I Inhibitors, NSC 743400 and NSC 725776
Journal of Pharmaceutical and Biomedical Analysis
Clinical Biochemistry
Drug Discovery
Analytical Chemistry
Spectroscopy
Pharmaceutical Science
Merging the HSC and NSC: Stronger Together
Industrial NSC Hydrometallurgical Precious Metals Recycle
SOJ Materials Science & Engineering
A Phase I Trial of SJG-136 (NSC#694501) in Advanced Solid Tumors
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Inhibition of Mammalian Topoisomerase I by Xestoquinone and Halenaquinone
Bioscience, Biotechnology and Biochemistry
Organic Chemistry
Applied Microbiology
Molecular Biology
Biochemistry
Analytical Chemistry
Medicine
Biotechnology
The Research on NSC Key Service Mechanism in Mobile Network
Oxidative Stress in NSC-741909-induced Apoptosis of Cancer Cells
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Plastrum Testudinis Extracts Promote NSC Differentiation Into Dopaminergic Neuron by Regulating the Interaction of TET1 and FoxA2
Evidence-based Complementary and Alternative Medicine
Alternative Medicine
Complementary
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
Chemical Reviews
Chemistry
